NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 174 filers reported holding NEVRO CORP in Q4 2016. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $86,090 | -23.1% | 2,174 | -9.7% | 0.00% | -42.9% |
Q3 2022 | $112,000 | -23.8% | 2,408 | -28.2% | 0.01% | 0.0% |
Q2 2022 | $147,000 | +4.3% | 3,354 | +72.4% | 0.01% | +16.7% |
Q1 2022 | $141,000 | -18.0% | 1,945 | -8.2% | 0.01% | 0.0% |
Q4 2021 | $172,000 | -61.8% | 2,118 | -45.2% | 0.01% | -57.1% |
Q3 2021 | $450,000 | -38.4% | 3,864 | -12.4% | 0.01% | -17.6% |
Q2 2021 | $731,000 | +18.9% | 4,412 | 0.0% | 0.02% | +13.3% |
Q1 2021 | $615,000 | -33.2% | 4,412 | -17.0% | 0.02% | -25.0% |
Q4 2020 | $921,000 | -20.3% | 5,318 | -35.9% | 0.02% | -20.0% |
Q3 2020 | $1,155,000 | +259.8% | 8,295 | +47.5% | 0.02% | +257.1% |
Q3 2018 | $321,000 | -19.8% | 5,625 | +12.4% | 0.01% | -22.2% |
Q2 2018 | $400,000 | -7.8% | 5,005 | 0.0% | 0.01% | -10.0% |
Q1 2018 | $434,000 | +25.4% | 5,005 | 0.0% | 0.01% | +25.0% |
Q4 2017 | $346,000 | -57.9% | 5,005 | -44.6% | 0.01% | -57.9% |
Q3 2017 | $821,000 | +50.1% | 9,029 | +22.8% | 0.02% | +58.3% |
Q2 2017 | $547,000 | +10.3% | 7,352 | +54.6% | 0.01% | +9.1% |
Q3 2016 | $496,000 | – | 4,754 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BRAIDWELL LP | 1,776,368 | $45,155,275 | 1.48% |
ARMISTICE CAPITAL, LLC | 2,356,000 | $59,889,520 | 0.87% |
Rock Springs Capital Management LP | 1,211,400 | $30,793,788 | 0.73% |
ArrowMark Colorado Holdings LLC | 1,817,189 | $46,192,944 | 0.51% |
Palo Alto Investors LP | 186,259 | $4,734,704 | 0.38% |
K2 PRINCIPAL FUND, L.P. | 51,000 | $1,296,420 | 0.30% |
TD Capital Management LLC | 84,648 | $2,151,752 | 0.26% |
Point72 Europe (London) LLP | 73,800 | $1,875,996 | 0.25% |
Venator Management LLC | 25,000 | $636 | 0.23% |
Virtus Investment Advisers, Inc. | 12,500 | $317,750 | 0.22% |